246 related articles for article (PubMed ID: 2614012)
21. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
[TBL] [Abstract][Full Text] [Related]
22. [Tobacco smoking in patients with hyperthyroidism].
Warmuz-Stangierska I; Czarnywojtek A; Florek E; Rabska-Pietrzak B; Sawicka J; Sowiński J
Przegl Lek; 2005; 62(10):992-4. PubMed ID: 16521936
[TBL] [Abstract][Full Text] [Related]
23. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
Wiersinga WM; Smit T; van der Gaag R; Koornneef L
J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
[TBL] [Abstract][Full Text] [Related]
24. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR).
Heuer M; Aust G; Ode-Hakim S; Scherbaum WA
Thyroid; 1996 Apr; 6(2):97-106. PubMed ID: 8733879
[TBL] [Abstract][Full Text] [Related]
25. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.
Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR
J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048
[TBL] [Abstract][Full Text] [Related]
26. Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
Lanzolla G; Puccinelli L; Giudetti M; Comi S; Menconi F; Maglionico MN; Posarelli C; Figus M; Marcocci C; Marinò M
J Endocrinol Invest; 2023 Feb; 46(2):337-344. PubMed ID: 36030301
[TBL] [Abstract][Full Text] [Related]
27. Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.
Wall JR; Triller H; Boucher A; Bernard NF; Salvi M; Ludgate M
J Endocrinol Invest; 1993 Dec; 16(11):863-8. PubMed ID: 7511621
[TBL] [Abstract][Full Text] [Related]
28. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
[TBL] [Abstract][Full Text] [Related]
30. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
Gopinath B; Ma G; Wall JR
Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte migration test (LMT) in patients with thyroid disease: the response to human thyroid subcellular fractions.
Galluzzo A; Filardo C; Giordano C; Sparacino G; Bompiani GD
J Endocrinol Invest; 1981; 4(2):173-6. PubMed ID: 6895083
[TBL] [Abstract][Full Text] [Related]
32. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
33. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.
Heufelder AE; Bahn RS
Clin Exp Immunol; 1993 May; 92(2):296-302. PubMed ID: 8097976
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of simple nodular goiter and Hashimoto's thyroiditis in current, previous, and never smokers in a geographical area with mild iodine deficiency.
Rendina D; De Palma D; De Filippo G; De Pascale F; Muscariello R; Ippolito R; Fazio V; Fiengo A; Benvenuto D; Strazzullo P; Galletti F
Horm Metab Res; 2015 Mar; 47(3):214-9. PubMed ID: 25153684
[TBL] [Abstract][Full Text] [Related]
35. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
Chan JY; Walfish PG
J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
[TBL] [Abstract][Full Text] [Related]
36. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
[TBL] [Abstract][Full Text] [Related]
37. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy.
Ozata M; Bolu E; Sengül A; Altinsoy HI; Turan M; Corakci A; Hacibektasoglu A; Gundogan MA
Endocr J; 1996 Oct; 43(5):517-25. PubMed ID: 8980891
[TBL] [Abstract][Full Text] [Related]
38. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
39. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Krassas GE; Segni M; Wiersinga WM
Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
[TBL] [Abstract][Full Text] [Related]
40. The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series.
Ferrari SM; Fallahi P; Ruffilli I; Elia G; Ragusa F; Benvenga S; Antonelli A
Autoimmun Rev; 2019 Mar; 18(3):287-292. PubMed ID: 30639646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
